Compatibility of stabilized whole blood products with CD4 technologies and their suitability for quality assessment programs.
about
Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical developmentDuplicate analysis method: a cheaper alternative to commercial IQC materials in limited resource settings for monitoring CD4 testing.Automation for Clinical CD4 T-Cell Enumeration, a Desirable Tool in the Hands of Skilled Operators.QASI: A collaboration for implementation of an independent quality assessment programme in India.
P2860
Compatibility of stabilized whole blood products with CD4 technologies and their suitability for quality assessment programs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Compatibility of stabilized wh ...... r quality assessment programs.
@ast
Compatibility of stabilized wh ...... r quality assessment programs.
@en
Compatibility of stabilized wh ...... r quality assessment programs.
@nl
type
label
Compatibility of stabilized wh ...... r quality assessment programs.
@ast
Compatibility of stabilized wh ...... r quality assessment programs.
@en
Compatibility of stabilized wh ...... r quality assessment programs.
@nl
prefLabel
Compatibility of stabilized wh ...... r quality assessment programs.
@ast
Compatibility of stabilized wh ...... r quality assessment programs.
@en
Compatibility of stabilized wh ...... r quality assessment programs.
@nl
P2093
P2860
P1433
P1476
Compatibility of stabilized wh ...... r quality assessment programs.
@en
P2093
Adrienne F A Meyers
Margot Plews
Michèle Bergeron
Paul Sandstrom
Peggy Seely
T Blake Ball
Tamsir O Diallo
Xuefen Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0103391
P407
P577
2014-08-08T00:00:00Z